Stay updated on Inotuzumab Ozogamicin in ALL Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin in ALL Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin in ALL Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.3.3 was added and the footer now removes 'HHS Vulnerability Disclosure' and the 'Revision: v3.3.2' entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry (v3.3.2) was added to the Record History, and a previous revision (v3.3.1) was removed. This reflects administrative updates to the version history rather than substantive content changes.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry v3.3.1 was added to the Record History, and the entry for v3.2.0 was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the page header notice about government funding and operating status; it did not pertain to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check61 days agoChange DetectedRecord History shows several status updates: Version 2 (2018-08-01) added Study Status Oversight; Version 3 (2018-10-22) revised Study Status; Version 4 (2020-06-03) updated Recruitment Status; Version 5 (2021-12-31) updated Recruitment Status and Location details.SummaryDifference0.1%

- Check89 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference13%

Stay in the know with updates to Inotuzumab Ozogamicin in ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin in ALL Clinical Trial page.